[go: up one dir, main page]

MX2018003643A - Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne. - Google Patents

Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne.

Info

Publication number
MX2018003643A
MX2018003643A MX2018003643A MX2018003643A MX2018003643A MX 2018003643 A MX2018003643 A MX 2018003643A MX 2018003643 A MX2018003643 A MX 2018003643A MX 2018003643 A MX2018003643 A MX 2018003643A MX 2018003643 A MX2018003643 A MX 2018003643A
Authority
MX
Mexico
Prior art keywords
composition
acne
treatment
trifarotene
enguage
Prior art date
Application number
MX2018003643A
Other languages
English (en)
Other versions
MX382169B (es
Inventor
Nadau-Fourcade Karine
Christophe BUGE Jean-
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2018003643A publication Critical patent/MX2018003643A/es
Publication of MX382169B publication Critical patent/MX382169B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición autoespumante que contiene trifaroteno, destinada a una aplicación tópica sin enjuague y destinada a ser aplicada sobre la piel, que comprende: - al menos una composición intermediaria B que comprende un agente generador de gas, - al menos una composición intermedia A que comprende un agente activador del agente generador de gas, y - el trifaroteno o una de sus sales farmacéuticamente aceptables contenido en al menos una de las composiciones intermediarias A y B. Esta composición está principalmente destinada al tratamiento del acné. La presente invención se refiere igualmente a un kit o un recipiente único con varios compartimientos que contienen una composición tal.
MX2018003643A 2015-09-29 2016-09-27 Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne. MX382169B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1559202A FR3041536B1 (fr) 2015-09-29 2015-09-29 Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
PCT/EP2016/073009 WO2017055292A1 (fr) 2015-09-29 2016-09-27 Mousse chimique non rincée contenant du trifarotène, et son utilisation dans le traitement de l'acné

Publications (2)

Publication Number Publication Date
MX2018003643A true MX2018003643A (es) 2018-04-30
MX382169B MX382169B (es) 2025-03-13

Family

ID=54545345

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018003643A MX382169B (es) 2015-09-29 2016-09-27 Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne.

Country Status (9)

Country Link
US (1) US11020347B2 (es)
EP (1) EP3355857A1 (es)
JP (1) JP2018529771A (es)
KR (1) KR20180057714A (es)
CN (1) CN108289839A (es)
AU (1) AU2016330787B2 (es)
FR (1) FR3041536B1 (es)
MX (1) MX382169B (es)
WO (1) WO2017055292A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114788791A (zh) 2017-06-23 2022-07-26 宝洁公司 用于改善皮肤外观的组合物和方法
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
FR3095241B1 (fr) * 2019-04-17 2021-06-25 Safran Aircraft Engines Entrée d’air de nacelle de turboréacteur comprenant une conduite de circulation pour favoriser une phase d’inversion de poussée
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
JP4659980B2 (ja) 1997-11-07 2011-03-30 株式会社メディオン・リサーチ・ラボラトリーズ 二酸化炭素含有粘性組成物
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6177092B1 (en) 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems
US6133310A (en) 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
FR2830415B1 (fr) 2001-10-09 2004-07-09 Rhodia Chimie Sa Utilisation d'une composition a base de gomme xanthane en tant que stabilisant de mousses molles, et les mousses a base de cette composition
EP1556009B2 (en) * 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US20050123487A1 (en) 2003-12-08 2005-06-09 Spadini Alessandro L. Stable nonaqueous liquid reactive skin care and cleansing packaged product
US20060057075A1 (en) 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
CA2548532C (en) 2004-09-27 2014-12-02 Jan De Rijk Methods and compositions for treatment of water
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
FR2924944A1 (fr) 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
US10589134B2 (en) 2008-01-30 2020-03-17 Kimberly-Clark Worldwide, Inc. Hand health and hygiene system for hand health and infection control
DE102008029357A1 (de) 2008-06-20 2009-12-24 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Schäumende kosmetische Zubereitung
JP2012516320A (ja) 2009-01-30 2012-07-19 イッスム リサーチ デベロプメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム リミテッド 爪および皮膚を処置するための組成物
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
US20100291160A1 (en) 2009-05-13 2010-11-18 Carver David R Pharmaceutical system for trans-membrane delivery
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US20110236503A1 (en) 2010-03-23 2011-09-29 Cosmalabs International, Llc Topical Skincare Composition
WO2012001065A2 (en) 2010-06-30 2012-01-05 Galderma Research & Development Method for preventing or treating skin tumor
EP2620138B1 (en) 2010-09-24 2016-12-07 Daido Chemical Corporation Foam-type external skin preparation
FR2969492B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969493B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
FR2969491B1 (fr) 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
US9301935B2 (en) 2013-06-10 2016-04-05 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
EP3010487A4 (en) 2013-06-17 2016-12-07 Contract Pharmaceuticals Ltd NON-AEROSOL FOAM FOR TOPICAL ADMINISTRATION
CN113559083A (zh) * 2013-12-04 2021-10-29 盖尔德马研究及发展公司 包含类维生素a的脂质微胶囊
RU2016141961A (ru) 2014-03-28 2018-04-28 Галдерма Ресерч Энд Девелопмент Несмываемая химическая пена, содержащая пероксид бензоила
KR102363217B1 (ko) 2014-03-28 2022-02-14 갈데르마 리써어치 앤드 디벨로프먼트 벤조일 퍼옥시드를 함유하는 린스-오프 화학적 무스
CN104382863B (zh) 2014-11-29 2017-07-07 河南后羿实业集团有限公司 一种禽用伊维菌素泡腾颗粒
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Also Published As

Publication number Publication date
EP3355857A1 (fr) 2018-08-08
JP2018529771A (ja) 2018-10-11
AU2016330787B2 (en) 2022-04-21
US11020347B2 (en) 2021-06-01
MX382169B (es) 2025-03-13
FR3041536A1 (fr) 2017-03-31
US20180280297A1 (en) 2018-10-04
AU2016330787A1 (en) 2018-05-17
CN108289839A (zh) 2018-07-17
FR3041536B1 (fr) 2018-11-30
KR20180057714A (ko) 2018-05-30
WO2017055292A1 (fr) 2017-04-06

Similar Documents

Publication Publication Date Title
MX378653B (es) Composicion limpiadora auto-espumante para enjuagar que contiene ivermectina.
BR112016022293A2 (pt) Composição que contém peróxido de benzoíla, uso cosmético de uma composição, medicamento destinado a uma aplicação tópica sobre a pele, kit e processo de preparação de uma composição autoespumante
MX2018003643A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne.
MX2019004440A (es) Champu concentrado que comprende una hidrofluoroolefina o una hidroclorofluoroolefina para suministrar beneficios de propiedades de dosificacion en espuma y composicionales.
MX388492B (es) Método para tratar el cabello o la piel con una composición para el cuidado personal en forma de espuma.
MX2017013582A (es) Metodo para el tratamiento del cabello con un acondicionador concentrado.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
BR112016022340A2 (pt) Composição, uso cosmético de uma composição, medicamento e kit
MX2016016216A (es) Metodo para el tratamiento del cabello con un acondicionador concentrado.
MX2016016217A (es) Metodo para el tratamiento del cabello con un acondicionador concentrado.
CL2020000220A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
MX2018003642A (es) Espuma quimica sin enjuage que contiene propionato de clobetasol y su uso en el tratamiento de la psoriasis.
MX2016010005A (es) Una composicion topica.
BR112018009425A8 (pt) novas formulações
MX2018003640A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.
MX2018007296A (es) Compuestos de isoindol.
MX2019006091A (es) Composicion de champu en seco.
CL2020000221A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
CL2017000329A1 (es) Mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
MX2018003647A (es) Espuma quimica sin enjuague que contiene brimonidina y su uso en el tratamiento de la rosacea.
BR112016022299A2 (pt) Composição que contém adapaleno e peróxido de benzoíla, uso cosmético de uma composição, medicamento destinado a uma aplicação tópica, kit e processo de preparação de uma composição
MX2018003549A (es) Composicion limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris.
PE20151300A1 (es) Composicion antifungica topica para el tratamiento de onicomicosis
AR095256A1 (es) Composiciones cosméticas con triciclodecan-amidas
CO7560107A1 (es) Composición antitranspirante